高海拔地区氯沙坦联合美托洛尔治疗高血压合并快速性心律失常的临床研究被引量：1

导出

摘要目的:分析氯沙坦与美托洛尔联合治疗高海拔地区高血压并快速性心律失常的临床疗效。方法:按就诊前后顺序,将82例高海拔地区(海拔2 200m)高血压并快速性心律失常患者分为观察组与对照组,观察组予以氯沙坦与美托洛尔治疗,对照组予以美托洛尔治疗。观察与比较两组患者的临床疗效。结果:观察组患者治疗后的总有效率(92.7%)高于对照组(73.2%),差异有统计学意义(P<0.05);观察组患者治疗后血压低于对照组,差异有统计学意义(P<0.05)。结论:对高血压并快速性心律失常患者采取氯沙坦与美托洛尔联合治疗,效果佳,值得临床推广应用。

作者陈嘉龙

机构地区青海省西宁市第一人民医院

出处《高原医学杂志》 CAS 2016年第2期31-32,共2页 Journal of High Altitude Medicine

关键词高海拔地区高血压快速性心律失常氯沙坦

分类号 R544.1 [医药卫生—心血管疾病] R541.7 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献4

1潘晓兰,李文静,但东梅,唐丹.氯沙坦联合美托洛尔治疗高血压合并快速性心律失常的临床观察[J].中国社区医师,2015,31(24):13-13. 被引量：3
2邬松林,黄从新.氯沙坦对老年高血压患者室性心律失常的影响[J].中华老年医学杂志,2011,30(1):24-26. 被引量：15
3迟玉法,赵庆.氯沙坦对室性心律失常的临床研究[J].中国基层医药,2013,20(13):2036-2038. 被引量：1
4王玉华.缬沙坦联合美托洛尔治疗高血压合并快速性心律失常疗效评价[J].检验医学与临床,2014,11(21):3045-3046. 被引量：18

二级参考文献41

1Wachtell K, Gerdts E, Aurigemma GP, et al. Intreatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Blood Press, 2010,19 : 169-175.
2Nomura M, Kawano T, Nakayasu K, et al. The effects of losartan on signal-averaged P wave in patients with atrial fibrillation. Int J Cardiol, 2008, 126:21-27.
3Okin PM, Wachtell K, Kjeldsen SE, et al. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study. Circ Arrhythm Electrophysio1,2008,1 : 337 343.
4Butz S, Driamov S, Remondino A, et al. Losartan but not enalaprilat acutely reduces reperfusion ventricular tachyarrhythmias in hypertrophied rat hearts after low-flow ischaemia. J Pharm Pharmacol, 2004,56 .. 521-528.
5Wachtell K, I.ehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol, 2005,45 : 712-719.
6Gtinther S, Baba HA, Hauptmann S, et al. Losartan reduces mortality in a genetic model of heart failure. Naunyn Schmiedebergs Arch Pharmacol, 2010, 382: 2G5 278.
7Stein M, Boulaksil M, Jansen JA, et al. Reduction of fibrosis-related arrhythmias by chronic renin- angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol, 2010,299:H310-321.
8Zakynthinos E, Pierrutsakos CH, Daniil Z, et al. I.osartan controlled blood pressure and reduced left ventricular hypertrophy but did not alter arrhythmias in hypertensive men with preserved systolic function. Angiology, 2005,56 : 439-449.
9Pitt OL, Marleen N, Abdul AO, et al. Irbesartan reduces QT dispersion in hypertensive individuals. Hypertension, 1999,33 : 713-718.
10Swedberg K,Kjekshus J. Effects of enalapril on mortality in severecongestive heart failure : results of the Cooperative North Scandi-navian Enalapril Survival Study ( CONSENSUS ) . Am J Cardiol,1988,62(2) :60A-66A.